In summary, our results for the first time show that ginsenoside Rh7 can significantly inhibit the proliferation and metastatic potentials of NSCLC cells ILF3-AS1/miR-212/SMAD1 axis. The gene discussed is SMAD1; the disease is non-small cell lung carcinoma.